Hip Innovation Technology, LLC

Hip Innovation Technology, LLC (HIT) is a privately held orthopedic device company based in Woodstock, United States, and formed in 2011. The company describes its mission as providing market-leading orthopedic device solutions, with a commitment to innovative technologies that deliver meaningful product differentiation and advance both quality of life and quality of care for patients and health care providers. Its stated focus is the development of differentiated hip implant technology rather than a broad portfolio of established devices. The company's lead product technology is the Reverse Hip Replacement System (Reverse HRS), which is described as being in development. According to the company, the Reverse HRS was rationally designed to optimize the benefits of currently marketed hip systems while addressing additional unmet clinical needs. HIT characterizes the Reverse HRS as a unique hip implant design that it believes represents breakthrough technology and a significant advancement for Total Hip Arthroplasty (THA). The company states that world-class device design and rigorous research and development work have been ongoing for over four years. HIT's family of Reverse HRS device offerings includes component and monoblock hip implant systems with differentiated features and benefits compared with currently marketed systems. The company also develops state-of-the-art surgical instruments to support the Reverse HRS implant systems, combining best-in-class designs with novel, patented elements. Its website organizes information around leadership, management, advisory board, board of directors, scientific development board, market overview, clinical need, opportunity for innovation, product information, product videos, product testing, market research, investor relations, and news. As a privately held company, HIT is not listed on a public stock exchange. Its public materials emphasize research, testing, and investor relations, consistent with a development-stage medical device company seeking to commercialize a novel hip arthroplasty platform. The company's headquarters location is given as Woodstock in the United States.

Hip Innovation Technology, LLC (HIT) was formed in 2011 as a privately held company focused on orthopedic device solutions. From its base in Woodstock, United States, the company set out to develop differentiated hip implant technology rather than to compete across the full range of orthopedic products. Its public materials describe a commitment to innovative technologies that provide meaningful product differentiation and advance the quality of life and quality of care for patients and health care providers. The central project of the company has been the Reverse Hip Replacement System (Reverse HRS). HIT states that the Reverse HRS was rationally designed to optimize the benefits of currently marketed hip systems while providing additional solutions to unmet clinical need. The company characterizes the design as a unique hip implant that it believes represents breakthrough technology and a significant advancement for Total Hip Arthroplasty (THA). According to HIT, world-class device design and rigorous research and development work have been ongoing for over four years, indicating a sustained development effort behind the platform. HIT's Reverse HRS family includes component and monoblock hip implant systems featuring differentiated features and benefits compared with currently marketed systems. To support these implants, the company has developed state-of-the-art surgical instruments that combine best-in-class designs with novel, patented elements. The company's website presents a structured body of work around the platform, including product overviews, features and benefits, surgical instruments, product videos covering component design, skeletal movement, cadaver stability, and extreme incline, as well as product testing that includes bench-level tests and cadaver studies. It also provides market research and investor relations sections. As a privately held, development-stage medical device company, HIT has not been publicly listed. Its governance and advisory structure, as reflected on its website, includes leadership, management, an advisory board, a board of directors, and a scientific development board. The company continues to present the Reverse HRS as its lead product technology in development, with the aim of commercializing a novel hip arthroplasty system.

• 2011

  Hip Innovation Technology, LLC is formed as a privately held company.

• The company conducts over four years of research and development on the Reverse Hip Replacement System (Reverse HRS).

• HIT develops a family of Reverse HRS component and monoblock hip implant systems along with supporting surgical instruments.

Market-leading orthopedic device solutions through differentiated, innovative hip implant technology, with the Reverse HRS positioned as breakthrough technology for Total Hip Arthroplasty.

• Reverse Hip Replacement System (Reverse HRS)

  Lead product technology in development; a unique hip implant design intended to optimize currently marketed hip system benefits and address unmet clinical need in Total Hip Arthroplasty.

• Reverse HRS component and monoblock hip implant systems

  Family of device offerings featuring differentiated features and benefits versus currently marketed systems.

• Reverse HRS surgical instruments

  State-of-the-art instruments combining best-in-class designs with novel, patented elements to support Reverse HRS implant systems.

1. 1Hip Innovation Technology - Providing Market-leading Orthopedic Device Solutionshipinnovationtechnology.com
2. 2Hip Innovation Technology (United States) - Wikidatawikidata.org